BIOHAVEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to BIOHAVEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS

Biohaven Pharma (BHVN) Misses Q4 EPS by 22c, Revenue Beats

February 25, 2022 7:04 AM EST

Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($2.32), $0.22 worse than the analyst estimate of ($2.10). Revenue for the quarter came in at $190 million versus the consensus estimate of $169.78 million.

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

... More